Publication | Closed Access

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

InflammationHypertensionHeart FailureChronic Heart FailureSoluble Adhesion MoleculesCardiovascular DiseaseImmunologyCardiovascular PharmacologyReceptor AntagonistEndothelial DysfunctionVascular BiologyCardiovascular FunctionMedicineCardiology